is lipo c fda approved Lipo-C Injection FDA approves i-Lipo fat-reduction device

Mechanistically, TMAO exacerbates IBD pathogenesis by modulating key signaling pathwaysincluding endoplasmic reticulum stress (ERS) via protein kinase RNA-like endoplasmic reticulum kinase (PERK) activation, NF-B-driven proinflammatory cytokine production, and NLRP3 inflammasome-mediated pyroptosisthereby disrupting intestinal epithelial integrity, amplifying macrophage and T cell activation, and skewing immune homeostasis toward a proinflammatory milieu

The anti-glycation effect is primarily attributed to decarboxy carnosine, which blocks AGE cross-linking reactions and protects target proteins from modification 23

For better results, our expert will suggest some after-treatment care which needs to be followed properly

& Rajab, K